You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 20, 2025

Details for Patent: 11,077,096


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,077,096
Title:Modified release compositions comprising tacrolimus
Abstract: A modified release composition comprising tacrolimus releases less than 20% w/w of the active ingredient within 0.5 hours when subjected to an in vitro dissolution test using USP Paddle method and using 0.1 N HCl as dissolution medium and has increased bioavailability by effectively reducing or even avoiding the effects of CYP3A4 metabolism. The modified composition may be coated with an enteric coating; and/or may comprise a solid dispersion or a solid solution of tacrolimus in a hydrophilic or water-miscible vehicle and one or more modifying release agents; and/or may comprise a solid dispersion or a solid solution of tacrolimus in an amphiphilic or hydrophobic vehicle and optionally one or more modifying release agents.
Inventor(s): Holm; Per (Vanlose, DK), Norling; Tomas (Lyngby, DK)
Assignee: VELOXIS PHARMACEUTICALS INC. (Cary, NC)
Application Number:15/677,938
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,077,096

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article delves into the details of United States Patent 11,077,096, which pertains to "Modified release compositions comprising tacrolimus."

Overview of the Patent

Patent Number and Details

  • The patent in question is US11077096B2, titled "Modified release compositions comprising tacrolimus."[4]

Inventors and Assignees

  • While the specific inventors and assignees are not detailed in the provided sources, this information can typically be found in the patent document itself.

Claims and Scope

Independent Claims

  • The patent scope is often determined by the independent claims, which define the broadest aspects of the invention. For US11077096B2, the independent claims would outline the core components and functionalities of the modified release compositions containing tacrolimus.

Claim Language and Metrics

  • Research suggests that the scope of a patent can be measured using metrics such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Technical Details

Composition and Release Profile

  • The patent describes modified release compositions that include tacrolimus, an immunosuppressive drug. A key feature of these compositions is that they release less than 20% w/w of the active ingredient within 0.5 hours when subjected to an in vitro test. This controlled release profile is critical for the therapeutic efficacy and safety of the drug[4].

Formulation and Ingredients

  • The composition may include various excipients and polymers to achieve the desired release profile. The specific formulation details, such as the types and amounts of ingredients, are crucial for replicating and understanding the invention.

Patent Family and Global Dossier

Global Dossier

  • The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including all related applications filed at participating IP Offices. This service is useful for understanding the global landscape of similar patents and the status of related applications[1].

Related Applications

  • By accessing the Global Dossier, one can identify other patents or applications related to US11077096B2, which may provide insights into the broader intellectual property strategy of the inventors or assignees.

Legal and Practical Considerations

Patent Assignment and Ownership

  • Changes in ownership or assignments of the patent can be searched through the Patent Assignment Search website. This is important for understanding the current legal status and ownership of the patent[1].

Potential Litigation and Licensing

  • The scope and claims of a patent can significantly impact its validity and the likelihood of litigation or licensing agreements. Broader claims may increase the risk of litigation, while narrower claims may reduce this risk but also limit the protection scope[3].

Public Access and Search Facilities

USPTO Public Search Facility

  • The USPTO Public Search Facility in Alexandria, VA, provides public access to patent and trademark information. Trained staff are available to assist users in searching and understanding patent documents, including those related to US11077096B2[1].

Online Resources

  • Online platforms like Google Patents and the USPTO website offer comprehensive search tools for finding and analyzing patent documents. These resources are essential for conducting thorough patent searches and understanding the patent landscape[1][4].

Future Implications and Small Claims Courts

Small Claims Patent Court

  • There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are resolved, especially for smaller entities. This could potentially affect the enforcement and defense of patents like US11077096B2[5].

Key Takeaways

  • Patent Scope and Claims: Understanding the independent claims and their metrics is crucial for determining the patent's scope and validity.
  • Technical Details: The modified release compositions of US11077096B2 are characterized by a specific release profile, which is critical for therapeutic efficacy.
  • Global Dossier: This service helps in understanding the global patent family and related applications.
  • Legal Considerations: Changes in ownership and the potential for litigation or licensing agreements are important aspects to consider.
  • Public Access: Utilizing public search facilities and online resources is essential for thorough patent analysis.

FAQs

Q: What is the main subject of United States Patent 11,077,096? A: The main subject is modified release compositions comprising the immunosuppressive drug tacrolimus.

Q: How can I access the full details of the patent? A: You can access the full details through online platforms like Google Patents or the USPTO website.

Q: What is the significance of the release profile in this patent? A: The release profile ensures that less than 20% w/w of the active ingredient is released within 0.5 hours, which is critical for therapeutic efficacy and safety.

Q: How can I find related patents or applications? A: You can use the Global Dossier service provided by the USPTO to view related applications filed at participating IP Offices.

Q: What are the potential legal implications of the patent scope and claims? A: The scope and claims can impact the validity of the patent and the likelihood of litigation or licensing agreements.

Sources

  1. USPTO: Search for patents - USPTO
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov
  3. SSRN: Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. Google Patents: Modified release compositions comprising tacrolimus - Google Patents
  5. ACUS: U.S. Patent Small Claims Court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,077,096

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 11,077,096

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
DenmarkPA 2003-01232Aug 29, 2003
DenmarkPA 2003-01837Dec 11, 2003
DenmarkPA 2004-00079Jan 21, 2004
DenmarkPA 2004-00463Mar 23, 2004
DenmarkPA 2004-00467Mar 23, 2004

International Family Members for US Patent 11,077,096

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 473003 ⤷  Try for Free
Austria 531368 ⤷  Try for Free
Australia 2004267909 ⤷  Try for Free
Australia 2004267910 ⤷  Try for Free
Brazil PI0413927 ⤷  Try for Free
Brazil PI0414000 ⤷  Try for Free
Canada 2537041 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.